-
1 month ago | 
fredhutch.org | Sabrina Richards
Jerome’s lab, in the Vaccine and Infectious Disease Division at Fred Hutch, focuses on viruses that persist in their hosts and evade the immune system.
While viruses like influenza come and go, others can set up permanent homes in our cells. Viruses like herpes simplex virus (HSV), hepatitis B, HIV and (occasionally) human papillomavirus, have found different ways to stick with us.
-
2 months ago | 
jons-online.com | Sabrina Richards
Brand-new cancer drugs typically take about 10 to 20 years to develop. And that’s just too long, as far as Fred Hutchinson Cancer Center’s Taran Gujral, PhD, is concerned — especially when it comes to rare cancers that are less likely to get attention from the pharmaceutical industry.
-
2 months ago | 
oncpracticemanagement.com | Dawn Holcombe |Diane Mapes |Sabrina Richards |Jan Hailey
By Diane Mapes; Sabrina RichardsA lab created a drug-matching platform that uses artificial intelligence (AI) to help researchers, clinicians and, most importantly, patients find additional uses for drugs that have already gone through clinical trials and received approval from the FDA. Read More ›Patient experience has become a cornerstone of medical office operations. It significantly influences patient outcomes, satisfaction, and overall well-being.
-
Jan 7, 2025 | 
fredhutch.org | Sabrina Richards
To ensure that vaccines work, they need to be tested in as wide an array of people as possible. In most vaccine trials, volunteer have their blood drawn in a clinical setting, but constraints in scheduling and commuting can make it difficult for many people to participate in these trials. To get more people involved, scientists are testing strategies that require less effort, less blood and — hopefully — fewerphlebotomy needles.
-
Dec 9, 2024 | 
fredhutch.org | Sabrina Richards
Driffin is no stranger to the challenges posed by an HIV diagnosis, nor to how critical good information is to ensuring someone can make the best decisions for themselves. Initially planning to become a doctor, he knew he wanted to improve health equity and help people stay healthy, but an HIV diagnosis shortly after Driffin graduated with his Bachelor of Science in biology appeared to be a roadblock.
-
Dec 5, 2024 | 
poz.com | Sabrina Richards
The COVID-19 pandemic made plain what many patients, clinicians and researchers have known for decades: people with weakened immune systems are much more vulnerable to infectious diseases. But immunocompromised patients are usually left out of large clinical trials that assess new treatments and vaccines, leaving a data gap that hampers clinical care.
-
Nov 20, 2024 | 
fredhutch.org | Sabrina Richards
Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred Hutch Cancer Center structural biologists Marie Pancera, PhD, and Nicholas Hurlburt, PhD, understand how subtleties of antibody-target interaction can guide development of better treatments and vaccines.
-
Nov 18, 2024 | 
fredhutch.org | Sabrina Richards
“There are a lot of potential synergies,” Boonyaratanakornkit said. “Right now, KSHV is kind of a black box. We can really move the needle if we focus resources and labs on the problem.”KSHV, also known as human herpesvirus 8, or HHV-8, is not as widespread as other herpesviruses, like HSV-1 and -2 and chickenpox. Most initial KSHV infections produce no symptoms and the virus has a varied geographic distribution.
-
Nov 12, 2024 | 
fredhutch.org | Sabrina Richards
As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can receive passive protection from maternal antibodies or from prophylactic monoclonal antibodies given after birth, babies are not eligible for a vaccine that will build their own immunity.
-
Oct 21, 2024 | 
fredhutch.org | Sabrina Richards |Robert Hood
“Right now, we’re reinventing the wheel every time,” Halasa said. “Through this eye-opening workshop and speaking with elected representatives and congressional staffers, I appreciate the value of a national network.”VISPR aims to define and reduce the local and international burden of acute respiratory and gastrointestinal infections in children, particularly infants and immunocompromised children.
